Apex Biotechnology Market Cap

Apex Biotechnology has a market cap or net worth of 3.19 billion as of April 29, 2025. Its market cap has decreased by -6.85% in one year.

Market Cap

3.19B

Enterprise Value

2.72B

Revenue

1.85B

Ranking

n/a

PE Ratio

25.16

Stock Price

32.00

Market Cap Chart

Since September 7, 2001, Apex Biotechnology's market cap has increased from 1.43B to 3.19B, an increase of 124.10%. That is a compound annual growth rate of 3.47%.

Market Cap History

Date	Market Cap	% Change
Apr 29, 2025	3.19B	6.15%
Dec 31, 2024	3.01B	-25.31%
Dec 29, 2023	4.03B	57.73%
Dec 30, 2022	2.55B	-1.73%
Dec 30, 2021	2.60B	10.38%
Dec 31, 2020	2.35B	-16.91%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	166.02B
Caliway Biopharmaceuticals	94.62B
Bora Pharmaceuticals Co., LTD.	70.34B
Lotus Pharmaceutical	56.23B
Oneness Biotech	29.26B
Polaris Group	28.38B
Lumosa Therapeutics	26.77B
Pegavision	25.55B

Market Cap Rankings